Methyl 1-[[2-(2,5-dimethylphenyl)-1,3-dioxoisoindole-5-carbonyl]amino]cyclopentane-1-carboxylate
C24H24N2O5 — CID 55560326
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 1-[[2-(2,5-dimethylphenyl)-1,3-dioxoisoindole-5-carbonyl]amino]cyclopentane-1-carboxylate
Methyl 1-[[2-(2,5-dimethylphenyl)-1,3-dioxoisoindole-5-carbonyl]amino]cyclopentane-1-carboxylate (PubChem CID 55560326) has the molecular formula C24H24N2O5 and a molecular weight of 420.47 g/mol. Its IUPAC name is methyl 1-[[2-(2,5-dimethylphenyl)-1,3-dioxoisoindole-5-carbonyl]amino]cyclopentane-1-carboxylate.
Molecular Properties
| Compound Name | Methyl 1-[[2-(2,5-dimethylphenyl)-1,3-dioxoisoindole-5-carbonyl]amino]cyclopentane-1-carboxylate |
|---|---|
| PubChem CID | 55560326 |
| Molecular Formula | C24H24N2O5 |
| Molecular Weight | 420.47 g/mol |
| Exact Mass | 420.17 |
| IUPAC Name | methyl 1-[[2-(2,5-dimethylphenyl)-1,3-dioxoisoindole-5-carbonyl]amino]cyclopentane-1-carboxylate |
| SMILES | COC(=O)C1(NC(=O)c2ccc3c(c2)C(=O)N(c2cc(C)ccc2C)C3=O)CCCC1 |
| InChI | InChI=1S/C24H24N2O5/c1-14-6-7-15(2)19(12-14)26-21(28)17-9-8-16(13-18(17)22(26)29)20(27)25-24(23(30)31-3)10-4-5-11-24/h6-9,12-13H,4-5,10-11H2,1-3H3,(H,25,27) |
| InChIKey | MHEXTGNUDFYBCX-UHFFFAOYSA-N |
| XLogP | 3.32 |
| TPSA | 92.78 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 420.47 |
| LogP ≤ 5 | 3.32 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 55560326 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.